Several phenolic constituents of propolis and their synthetic analogs were derivatized with L-lysine. The ability of these com plexes to alter complement activity was estimated in vitro in human serum. The influence of selected com plexes on C3 hemolytic activity via classical pathway (CP) and alternative pathway (A P ) and on zymosan-induced AP activation was determined. The results suppose that the anticomplement effect of the com plexes might be related to the interaction with C3 com plem ent component.
Introduction
ratios with L-lysine. The anticomplement potency A number of natural and synthetic substances have been reported to influence the complement system, which ensures the nonspecific protection of host against various infections. Propolis, a bee product, containing more than 200 individual con stituents (Greenaway et al., 1991; Garcia-Viguera et al., 1993) has been used in folk medicine for centuries. The phenolics represent about 50% of propolis composition (Bankova et al., 1982: Tomas-Barberan et al., Walker and Crane, 1987; Volpert and Elstner, 1994) and among them with proved biological activity are pinocembrin, galangine, cinnamic acid, caffeic acid and its esters (Ghisalberi, 1979 : Grunberger et al., 1988 Ikeno et al., 1991; Strehl et al., 1994; Marcucci, 1995) . Previously, we investigated a water-soluble deriva tive of propolis with L-lysine and proved that it possessed complement modulatory and antiin flammatory properties in vitro and in vivo . These data are in agreement with the reported data on antiinflammatory effect of propolis extracts and its flavanoids and phenolic constituents (Bauman et al., 1980; Khayyal et al., 1993; Pascual et al., 1994) . Immunomodulatory effect exhibited also complexes of cinnamic acid, obtained at different of these complexes depended on the lysine content and the results showed that one of the targets of their action was C3 complement component (Iva novska et al., 1993) . Guided by the chemical struc ture and content in the total mixture flavones, phe nolic acids and their esters identified in propolis were selected and derivatized with L-lysine. Lysine complexes of some synthetic ester analogs were also used in this study. The objective of the present work was to define the constituents responsible for the complement modulatory action of the whole mixture. The most effective of them can be further tested for antiinflammatory or adjuvant properties in appropriate in vivo models.
Materials and Methods

Preparation o f lysine complexes
The substances used in these experiments were obtained from the following sources: pinocembrin, pectolinarigenin and quercetin were isolated from propolis; caffeic acid was bought from Merck (Darmstadt, Germany); ferulic acid from T. Schuchardt (München); cinnamic and chlorogenic acid from Fluka (Buchs, Switzerland) and chrysin from Roth (Karlsruhe). Esters of phenolic acids were synthesized according to the method of Ban kova (1990) . Lysine complexes were prepared as described previously for cinnamic acid lysine com plexes (Ivanovska et al., 1993) . The amount of ly sine was determined by reaching full solubility of 0 9 3 9 -5 0 7 5 /9 7 /0 1 0 0 -0 0 6 0 $ 06.00 © 1997 V erlag der Z eitsch rift für N aturforschung. A ll rights reserved. D the complex in saline. For complement assays they were dissolved in veronal buffer and used within two days.
Complement inhibition assay
Classical pathway and AP activities were deter mined by the method of Klerx et al., (1983) . In the assay isotonic veronal buffer saline (VSB), pH 7.4, containing 0.15 mM Ca2+ and 0.5 mM Mg2+ (VSB2+, for CP) and VSB, containing 5 mM Mg2+ and 8 mM ethyleneglycol-bis-(2-aminoethyl)tetraacetic acid (VSB-EGTA, for AP) were used. Normal human serum (NHS) from healthy donors served as a complement source. Sensitized sheep red blood cells (sSRBC) were target cells in CP assay and uncoated rabbit erythrocytes (RaE) were target cells in the AP assay. NHS was preliminary titrated via both pathways in order to determine the dilu tion giving 50% hemolysis. Briefly, the inhibitory activity was determined as follows: 0.1 ml of seri ally diluted in VSB2+ lysine complexes were incu bated with 0.1 ml of appropriately diluted NHS (1:40 for CP and 1:4 for AP) for 30 min at 37 °C. After that 0.05 ml of 2% suspension of sSRBC (CP) or RaE (AP) were added. After incubation at 37 °C for 60 min (CP) or 45 min (AP) the resid ual hemolytic activity of NHS was measured spectrophotometrically at 405 nm. The percentage of inhibition was calculated by the formula:
% hemolysis of control Dose-response curves were drawn by plotting the inhibition against dilutions of the complexes and the concentration giving 50% inhibition of hemol ysis (IC50) was determined.
C3 residual activity
C3-deficient serum (R3) was obtained by incu bation of fresh NHS for 30 min at 37 °C with acti vated zymosan (final concentration 5 mg/ml). A volume of 0.1 ml undiluted NHS was incubated with 200 ^g of each complex diluted in 0.1 ml VSB for 30 min at 37 °C. The ability of NHS to restore hemolytic activity of R3 serum was measured as follows: serial dilutions of complex/NHS mixture in VSB2+ or in VSB-EGTA were made and 0.1 ml of 1:5 diluted R3 serum was added together with 0.05 ml of target erythrocytes.
Influence o f complexes on zymosan-induced A P activation
Activated zymosan (30 min boiling in saline) was added as 1% suspension in VSB-EGTA (0.02 ml) to 0.1 ml NHS for 20 min at 37 °C. The complexes were added simultaneously with the ac tivator at a final concentration of 200 |ig/ml. After centrifugation for separation of zymosan the resid ual AP activity of NHS was determined. Percen tage of the inhibition of complement hemolysis was calculated and compared to the samples where buffer was added instead of activator.
Results and Discussion
The complement system is the major factor in the pathogenesis of many infectious and inflam matory processes. The ability of lysine complex of propolis to affect complement activity in vitro and in vivo and the established relation with its immu nomodulatory and antiinflammatory properties was the reason to choose the complement assays for estimation the immunomodulatory capacity of lysine complexes of individual propolis constitu ents. The results in Table I show that some of the complexes tested exhibited high inhibitory effect on CP activity. If the concentration range for IC50 from 12.0 to 50.0 |ig/ml was taken for significant they might be arranged in the following order: benzyl-p-coumarate > benzyl caffeate, isoamyl caffeate > pectolinarigenin > cinnamic acid > phenetyl ferulate > chrysin > chlorogenic acid, benzylo-coumarate. Related to AP activity the highest inhibition was detected for chrysin, phenetyl feru late > cinnamic acid > benzyl caffeate > benzyl-pcoumarate > benzyl ferulate. Four of the com plexes (chrysin, phenetyl ferulate, benzyl caffeate and benzyl-p-coumarate) were capable to suppress strongly both, CP and AP activities. The com plexes of quercetin, benzyl sinapate and benzyl 3,4-dimethoxycinnamate showed no effect via both pathways. The inhibition did not correlate with the lysine content. The complexes of benzyl caffeate and phenetyl caffeate are with equal content of lysine and belong to the same chemical group but differ greatly, especially in regard to CP activity. If the present data are compared to the Table I . Effect of lysine derivatives on com plem ent activity (CP and A P) in normal human serum (NHS).
Substance3
Classical previous once, obtained for complexes of cinnamic acid with different content of lysine, a conclusion might be drawn that lysine can influence the bio logical activity of complexes but an exact struc ture/activity relationship has not been established. The IC50 values for some phenolic constituents are ten times lower than the IC50 values for the whole mixture (Table I , water soluble derivative of prop olis (WSD) v.s. cinnamic acid and benzyl-p-coumarate). This result at the one side points on the additive final effect of the WSD constituents and at the other side shows that the identification of the individual compounds with high activity is very perspective. Some of the complexes were exam ined for their effect on C3 functional activities via both pathways (Fig. 1) plexes of benzyl-p-coumarate, phenetyl ferulate > benzyl caffeate > caffeic acid. Since the inhibitory effect of the complexes was more expressed upon total AP and alternative C3 activities, three of them were tested in zymosan-induced AP activa tion. Results in Fig. 2 showed that zymosan caused 50% consumption of complement activity at the concentration used. Complexes of chrysin and phenetyl ferulate significantly potentiated zymo san action, which additionally decreased the resid ual activity of NHS. In contrast, the complex of benzyl caffeate in combination with zymosan low ered the effect of zymosan, which resulted in an increase of hemolysis. Most of the active com plexes affected definitely one of the pathways. The data confirmed the suggestion that C3 might be one of the target molecules. As a whole the inhibi tion of the alternative C3 activity was more ex pressed than that of the classical C3 activity. The application of complexes of chrysin, benzyl caf feate and phenetyl ferulate in zymosan-induced AP hemolytic assay indicated that their mode of action was not unique. The two esters, benzyl caf feate and phenetyl ferulate were with opposite in fluence on the process of activation. It is also pos sible that one complex might counteract two or more complement components.
In conclusion, some of the propolis constituents were accounted as complement inhibitory agents. Their derivatization with lysine greatly improved their solubility and made possible their in vivo ap plication without the side effects proper for alco hol or dimethylsulfoxide solutions. The application of complexes in various in vivo models is a logical next step to evaluate their use in real immune pro cesses and their possible use in practice.
